BPMC - Blueprint Medicines EPS beats by $0.05 beats on revenue May, 06 2020 07:06 AM Blueprint Medicines Corporation Blueprint Medicines (NASDAQ:BPMC): Q1 GAAP EPS of -$2.11 beats by $0.05.More news on: Blueprint Medicines Corporation, Earnings news and commentary, Healthcare stocks news, Read more ...